Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-001088-32Phase 2Completed
A Phase 2 trial of salbutamol in spinal muscular atrophy (SMA), sponsored by Carlo Besta Neurological Institute. Started Jul 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-001088-32.